Therapies for autoimmune and inflammatory diseases

NILO Therapeutics is focused on harnessing the connection between the nervous system and the immune system to develop innovative treatments for autoimmune and inflammatory diseases. The company is exploring how neuronal circuits can regulate immune responses, aiming to leverage this understanding to create therapies that target these pathways effectively. This approach highlights the potential for novel interventions that could alter disease progression by modulating the brain-body circuit.

The company's pipeline suggests a commitment to advancing its research into practical applications, with a focus on developing products that can address unmet medical needs in the realm of autoimmune and inflammatory conditions. By integrating insights from neuroscience and immunology, NILO Therapeutics is positioned to pioneer new therapeutic strategies that could significantly improve patient outcomes in these challenging areas of healthcare.

United States

NILO Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. Our experienced team brings together diverse interdisciplinary expertise to modulate immune responses via activation of neural circuits. United by our passion for discovering and translating novel biology, we are dedicated to advancing human health through transformative science.

NILO Therapeutics

Company Details